Pure Global AI
NCT06273566Not yet recruiting

French Validation of the AdT-Physio Scale

French Validation of the AdT-Physio Scale for Assessing Adherence and Perception of the Intervention of a Physiotherapist in Patients With Cystic Fibrosis
Pole Sante Grace de DieuClinicalTrials.govother
Verified
Study focus
Disease/Condition
Cystic Fibrosis
Drug/Device/Intervention
Questionnaire
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Pole Sante Grace de Dieu
Location
Caen, France
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Jul 31, 2025
Enrollment
121 participants
Primary outcome

AdT-Physio scale (Adherence to Treatment of Physiotherapy scale)

Summary

The goal of this observational study is to translate and validate the Adt-Physio scale in
 French, and to validate on a large number of patients the French translation of the
 Adt-Physio scale as a tool for evaluating adherence and perception of the intervention of a
 physiotherapist in patients with cystic fibrosis.
 
 participants will have to answer the French trans-AdT scale, the Brief Cope and GSES
 questionnaire.

ICD-10 classifications
Cystic fibrosisCystic fibrosis, unspecifiedCystic fibrosis with other manifestationsCystic fibrosis with pulmonary manifestationsCystic fibrosis with intestinal manifestations
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06273566
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06273566 through Pure Global AI's free database. This phase not specified trial is sponsored by Pole Sante Grace de Dieu and is currently Not yet recruiting. The study focuses on Cystic Fibrosis. Target enrollment is 121 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.